KIAA0101 has been described as a pro‐survival oncogene in several cancer types (Hosokawa et al., 2007; Zhu et al., 2013) and as a driver of cell cycle progression (Emanuele et al., 2011). The gene discussed is PCLAF; the disease is cancer.